SEC Filing Summary for BioStem Technologies, Inc. - Form 3 Filing

This filing details the ownership of securities by Barry Hassett, Chief Commercial Officer of BioStem Technologies, Inc. (BSEM). As of August 6, 2026, Hassett directly owns 4,503 shares of Common Stock. The filing also discloses various stock options and restricted stock units granted to Hassett, with specific vesting schedules detailed in the footnotes. These include stock options with exercise prices of $14.89 and $5.50, and restricted stock units, each representing a contingent right to one share of common stock. The vesting for these awards is staggered, with initial vesting occurring on anniversaries of the grant dates and the remainder vesting over subsequent periods.